Pharmacokinetics of levosimendan and its metabolites during and after a 24-hour continuous infusion in patients with severe heart failure
Year: 2002
Type: article
Study design: Clinical Trial
DOI: 10.5414/cpp40465
Institution: Orion Corporation (Finland)
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2032520387
